Table 2 Summary and comparison of outcome measures used in established benchmarking systems and in the first phase of EBMT benchmarking system (final column)
Outcome measure | BSBMT—UK | GITMO—Italy | SBSCT— Switzerland | DRST—Germany | BTR—Belgium | ABM—France | GETH —Spain | ABMTRR—Australia/New Zealand | CIBMTR—USA | Phase 1 EBMT |
|---|---|---|---|---|---|---|---|---|---|---|
1-year overall survival | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
3-year overall survival | Yes | No | Yes | No | Yes | No | No | Yes | No | No |
5-year overall Survival | Yes | No | Yes | Yes | No | No | No | No | No | No |
10-year overall survival | No | No | Yes | No | No | No | No | No | No | No |
1 year non-relapse mortality (NRM)/transplant-related mortality (TRM)a | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | No |
Relapse incidence at 1 year | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | No | No |
Completeness of follow-up—are you reporting completeness of follow-up to reporting centres? Yes/No | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes |
